Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 180

1.

Rituximab associated pneumonitis in antineutrophil cytoplasmic antibody-associated vasculitis.

Arulkumaran N, Suleman R, Cecconi M, Kiely P, Chua F.

J Clin Rheumatol. 2012 Jan;18(1):39-41. doi: 10.1097/RHU.0b013e31823ee5bf.

PMID:
22157278
2.

Refractory antineutrophil cytoplasmic antibody-associated vasculitis successfully treated with rituximab: a case report.

Horai Y, Miyamura T, Takahama S, Hirata A, Nakamura M, Ando H, Minami R, Yamamoto M, Suematsu E.

Nihon Rinsho Meneki Gakkai Kaishi. 2010;33(2):105-10. Review.

3.

Rituximab for remission maintenance in relapsing antineutrophil cytoplasmic antibody-associated vasculitis.

Smith RM, Jones RB, Guerry MJ, Laurino S, Catapano F, Chaudhry A, Smith KG, Jayne DR.

Arthritis Rheum. 2012 Nov;64(11):3760-9. doi: 10.1002/art.34583.

4.

Long-term observation of patients with anti-neutrophil cytoplasmic antibody-associated vasculitis treated with rituximab.

Stasi R, Stipa E, Del Poeta G, Amadori S, Newland AC, Provan D.

Rheumatology (Oxford). 2006 Nov;45(11):1432-6. Epub 2006 Apr 21.

PMID:
16632482
5.

Treatment of antineutrophil cytoplasmic antibody-associated vasculitis: update.

Santana AN, Woronik V, Halpern AS, Barbas CS.

J Bras Pneumol. 2011 Nov-Dec;37(6):809-16. Review. English, Portuguese.

6.

Association of ANCA-associated vasculitis-rheumatoid arthritis overlap syndrome in four patients: rituximab may be the right choice?

Szilasi M, Mátyus J, File I, Szücs G, Rákóczi E, Pfliegler G, Szabó Z, Végh E, Szekanecz Z.

Autoimmunity. 2012 Jun;45(4):304-9. doi: 10.3109/08916934.2012.677078. Epub 2012 Apr 10.

PMID:
22443800
7.

Rituximab versus azathioprine for maintenance in ANCA-associated vasculitis.

Guillevin L, Pagnoux C, Karras A, Khouatra C, Aumaître O, Cohen P, Maurier F, Decaux O, Ninet J, Gobert P, Quémeneur T, Blanchard-Delaunay C, Godmer P, Puéchal X, Carron PL, Hatron PY, Limal N, Hamidou M, Ducret M, Daugas E, Papo T, Bonnotte B, Mahr A, Ravaud P, Mouthon L; French Vasculitis Study Group.

N Engl J Med. 2014 Nov 6;371(19):1771-80. doi: 10.1056/NEJMoa1404231.

8.

Rituximab as maintenance therapy for anti-neutrophil cytoplasmic antibody-associated vasculitis.

Rhee EP, Laliberte KA, Niles JL.

Clin J Am Soc Nephrol. 2010 Aug;5(8):1394-400. doi: 10.2215/CJN.08821209. Epub 2010 May 24.

9.

B-cell depletion with rituximab for refractory head and neck Wegener's granulomatosis: a cohort study.

Martinez Del Pero M, Chaudhry A, Jones RB, Sivasothy P, Jani P, Jayne D.

Clin Otolaryngol. 2009 Aug;34(4):328-35. doi: 10.1111/j.1749-4486.2009.01968.x.

PMID:
19673980
10.

Rituximab in ANCA-associated vasculitis: fad or fact?

Fervenza FC.

Nephron Clin Pract. 2011;118(2):c182-8; discussion c188. doi: 10.1159/000321437. Epub 2010 Dec 16. Review.

11.

Refractory disease in antineutrophil cytoplasmic antibodies associated vasculitis.

Rutgers A, Kallenberg CG.

Curr Opin Rheumatol. 2012 May;24(3):245-51. doi: 10.1097/BOR.0b013e3283529756. Review.

PMID:
22410545
12.

[Severe Wegener's granulomatosis successfully treated with rituximab].

Semenkova EN, Krivosheev OG, Novikov PI, Osipenko VI, Nosova NR, Parfenova SA, Nikiforova NV, Borodin OO.

Ter Arkh. 2010;82(6):53-5. Russian.

PMID:
20731113
13.

Rituximab treatment for vasculitis.

Jayne D.

Clin J Am Soc Nephrol. 2010 Aug;5(8):1359-62. doi: 10.2215/CJN.05500610. Epub 2010 Jul 29. No abstract available.

14.

S3. Rituximab for ANCA-associated vasculitides: the French experience.

Charles P, Guillevin L.

Presse Med. 2013 Apr;42(4 Pt 2):534-6. doi: 10.1016/j.lpm.2013.01.050. Epub 2013 Feb 26. Review. No abstract available.

PMID:
23453207
15.

[The role of rituximab in the treatment of ANCA-associated systemic vasculitis].

Roccatello D, Vangelista A, Pani A.

G Ital Nefrol. 2011 Sep-Oct;28(5):474-88. Review. Italian.

PMID:
22028261
16.

Antineutrophil cytoplasmic antibody-associated vasculitis complicated with diffuse alveolar hemorrhage: a study of 12 cases.

Lin Y, Zheng W, Tian X, Zhang X, Zhang F, Dong Y.

J Clin Rheumatol. 2009 Oct;15(7):341-4. doi: 10.1097/RHU.0b013e3181b59581.

PMID:
20009969
17.

Successful treatment with rituximab in a patient with TTP secondary to severe ANCA-associated vasculitis.

Asamiya Y, Moriyama T, Takano M, Iwasaki C, Kimura K, Ando Y, Aoki A, Kikuchi K, Takei T, Uchida K, Nitta K.

Intern Med. 2010;49(15):1587-91. Epub 2010 Aug 2.

18.
19.

Treatment of antineutrophil cytoplasmic antibody-associated vasculitis with rituximab.

Cartin-Ceba R, Fervenza FC, Specks U.

Curr Opin Rheumatol. 2012 Jan;24(1):15-23. doi: 10.1097/BOR.0b013e32834d5730. Review.

PMID:
22089095
20.

S2. Rituximab for ANCA-associated vasculitis: the UK experience.

Jayne D.

Presse Med. 2013 Apr;42(4 Pt 2):532-4. doi: 10.1016/j.lpm.2013.01.049. Epub 2013 Mar 9. Review. No abstract available.

PMID:
23490639

Supplemental Content

Support Center